MAPK3 and prostate carcinoma: In colorectal and prostate cancer, T4 and T3 stimulate the membrane receptor integrin αvβ3, which activates some molecular pathways such as PI3-K and MAPK/ERK1/ 2, triggering cell proliferation and angiogenesis [65].